Showing results (1-10 of 197) with videos related to
Sort By:
Pageof 20
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 4, 2022
Cancer Modeling as Learning ExperienceRuth Etzioni, Jane LangeJournal of Medical Screening|February 3, 2023
Estimating stage-specific sensitivity for cancer screening testsPaul Pinsky, Jane Lange, Ruth EtzioniCancer|November 2, 2022
Modeling the impact of novel systemic treatments on lung cancer screening benefitsKemal Caglar Gogebakan, Jane Lange, Christopher G Slatore, et al.Evaluation & the Health Professions|January 28, 2021
A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction StudiesSerge Aleshin-Guendel, Jane Lange, Phyllis Goodman, et al.Journal of Medical Screening|June 12, 2023
Risk of cancer versus risk of cancer diagnosis? Accounting for diagnostic bias in predictions of breast cancer risk by race and ethnicityCharlotte C Gard, Jane Lange, Diana L Miglioretti, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2025
Sensitivity Measures in Studies of Cancer Early Detection BiomarkersYibai Zhao, Roman Gulati, Jane Lange, et al.Urologic Oncology|May 3, 2008
Statistical issues in the evaluation of screening and early detection modalitiesRuth EtzioniJAMA Network Open|October 9, 2025
Clinical Significance of a Multicancer Screening Trial With Stage-Based End PointsKemal Caglar Gogebakan, Jane Lange, Lukas Owens, et al.JCO Precision Oncology|May 18, 2026
Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling StudyKemal C Gogebakan, Jane Lange, Roman Gulati, et al.Journal of the National Cancer Institute|March 30, 2026
Measuring and defining screening benefit in a new era of cancer early detectionRuth Etzioni, Kemal Gogebakan, Roman Gulati, et al.Pageof 20